Company intelligence / Profile preview

Cardiovascular Institute of the South

Houma, Louisiana, United States

Ownership: Private
Employees: ~1150
Development stage: Other

Overview

CIS provides comprehensive, state-of-the-art cardiovascular care and is recognized for innovations in non-surgical treatments, advanced devices, and virtual care programs. It conducts ongoing clinical research but does not develop drugs/biologics in-house. Recent clinical 'firsts' include use of pioneering devices for limb-threatening ischemia and minimally invasive valve replacement.

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-pharmacological therapyDiagnosticsTelemedicine
Industry: Academic Hospital/University/Research

Partnerships

With medical device innovators for early device adoptionAcademic institutions for physician training and fellowships

Beyond the preview

Go deeper on Cardiovascular Institute of the South.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiovascular Institute of the South.

Explore the full profile